Efficacy of Reduced Gadolinium Dose in Contrast-Enhanced Breast MRI

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518549-27-00

Enrollment

100

Registered

2025-02-20

Start date

2025-08-14

Completion date

Unknown

Last updated

2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Qualitative Evaluation of image quality, Quantitative Evaluation of image quality

Detailed description

Diagnostic performance

Interventions

DRUGDOTAREM 0

DRUG5 mmol/ml oplossing voor injectie in injectieflacons.

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Qualitative Evaluation of image quality, Quantitative Evaluation of image quality	—

Secondary

Measure	Time frame
Diagnostic performance	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026